Table 2.
Antibiotic Sensitivity Pattern of E. coli and MSSA Isolates
Antibiotics | E.coli | MSSA |
---|---|---|
Sensitivity n (%) | Sensitivity n (%) | |
Cephalosporin | ||
Cefoxitin | NT | 130/130(100) |
Cefazolin | NT | (85.7) |
Cefuroxime | 5/88(5.7) | 30/47(63.8) |
Cefoperazone + Sulbactam | 18/30(60) | NT |
Ceftriaxone | 8/100(8) | 26/45(57.8) |
Ceftazidime | 9/29(31) | 6/16(37.5) |
Cefipime | 11/52(21.2) | 5/16(31.3) |
Cefixime | 2/58(3.5) | 5/17(29.4) |
Cefoperazone | 1/23(4.4) | NT |
Quinolones | ||
Levofloxacin | 28/82(34.2) | 32/45(71.1) |
Ciprofloxacin | 17/74(23) | 49/92(53.3) |
Norfloxacin | 10/44(22.7) | 26/55(47.3) |
Ofloxacin | 6/29(20.7) | 6/11(54.5) |
Nalidixic | 7/40(17.5) | NT |
Penicillin | ||
Oxacillin | NT | 8/8(100) |
Piperacillin + tazobactam | 71/111(71) | 10/17(58.8) |
Co-Amoxiclav | 12/86(14) | 13/25(52) |
Penicillin | NT | 30/104(28.9) |
Ampicillin | 7/104(6.7) | 12/46(26.1) |
Carbapenems | ||
Imipenem | 81/101(80.2) | 12/17(70.6) |
Ertapenem | 49/69(71) | NT |
Meropenem | 81/108(75) | 18/24(75) |
Macrolide | ||
Clarithromycin | NT | 16/19(84.2) |
Erythromycin | NT | 89/133(66.9) |
Aminoglycoside | ||
Amikacin | 87/103(84.5) | 101/112(90.2) |
Gentamicin | 51/96(53.1) | 85/108(78.7) |
Tobramycin | 30/59(50.9) | 39/59(66.1) |
Oxalidone | ||
Linezolid | NT | 121/127(95.3) |
Glycopeptide | ||
Vancomycin | NT | 122/122(100) |
Teicoplanin | NT | 46/66(69.7) |
Lincomycin | ||
Clindamycin | NT | 96/125(76.8) |
Phosphonic acid Antibiotics | ||
Fosfomycin | 48/48(100) | 3/3(100) |
Polymyxin | ||
Colistin | 58/60(96.7) | 11/11(100) |
Polymyxin B | 58/61(95.1) | 11/12(91.7) |
Antimycobacterials | ||
Rifampicin | NT | 51/58(87.9) |
Tetracycline | ||
Tigecycline | 52/56(92.9) | 54/58(93.1) |
Minocycline | 20/44(45.5) | 33/38(86.8) |
Tetracycline | 17/80(21.3) | 43/80(53.7) |
Sulfonamide | ||
Nitrofurantoin | 13/14(76.5) | NT |
Co-Trimoxazole | 12/81(14.8) | 21/83(25.3) |
Others | ||
Chloramphenicol | 33/41(80.5) | 71/77(92.2) |
Abbreviation: NT, Not Tested.